Efficacy and safety of quercetin and polyvinylpyrrolidone in treatment of patients with newly diagnosed destructive pulmonary tuberculosis in comparison with standard antimycobacterial therapy
International Journal of Mycobacteriology. 2016; 5 (4): 446-453
en Inglés
| IMEMR
| ID: emr-185107
ABSTRACT
Objective/background:
The objective/background of this work was to study the efficacy and safety of quercetin and polyvinylpyrrolidone [QP] in the treatment of patients with newly diagnosed destructive pulmonary tuberculosis in comparison with standard antimycobacterial therapy
Buscar en Google
Índice:
IMEMR (Mediterraneo Oriental)
Idioma:
Inglés
Revista:
Int. J. Mycobacteriology
Año:
2016
Similares
MEDLINE
...
LILACS
LIS